Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Antoine Babuty
CHU de Nantes
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
123
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Cyclophosphamide vs Rituximab for Eradicating Inhibitors in Acquired Hemophilia A: A Randomized Trial in 108 Patients
Number of pages: 31
Posted: 05 Sep 2023
Hervé Lévesque
,
Jean François Viallard
,
Estelle Houivet
,
Bernard Bonnotte
,
Sophie Voisin
,
Veronique Le cam-Duchez
,
François Maillot
,
Marc Lambert
,
Eric Liozon
,
Baptiste Hervier
,
Olivier Fain
,
Benoit Guillet
,
Jean Schmidt
,
Luminata Luca
,
Mikaël Ebbo
,
Nicole Ferreira-Maldent
, Antoine Babuty,
Laurent Sailler
,
Pierre Duffau
,
Virginie Barbay
,
Sylvain Audia
,
Jacques Bénichou
,
Julie Graveleau
and
Ygal Benhamou
CHU Rouen, CHU Bordeaux, CHU Rouen, CHU Dijon-Bourgogne, Université de Toulouse - CHU de Toulouse, Normandie University, CHRU Tours, CHU Lille, Dupuytren Hospital, Hôpital Saint-Louis, Hôpital Saint-Antoine, CHU Rennes, Amiens University Hospital, Poitiers University Hospital, CHU de Marseille, CHRU Tours, CHU de Nantes, Université de Toulouse - CHU de Toulouse, CHU Bordeaux, Normandie University, CHU Dijon-Bourgogne, CHU Rouen, CHU de Nantes and CHU Rouen
Downloads
123
(584,619)
View PDF
Download
Abstract:
acquired hemophilia A, rituximab, cyclophosphamider, randomized trial
Feedback
